Andrew Voglewede, MD
Otolaryngology · Boone, NCNPI 1699905315
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.6% of the total. 2025 is the largest year on record at $603, 2.2 times the $272 reported in 2019.
Across 93 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$569
- Sanofi$425
- Optinose US, Inc.$201
- Alk-abello, Inc$196
- AbbVie$115
- GSK$88
- plus $471 from 15 others
What the payments were for
- Food & beverage$2,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $569 |
| Sanofi | 19 | $425 |
| Optinose US, Inc. | 10 | $201 |
| Alk-abello, Inc | 10 | $196 |
| AbbVie | 7 | $115 |
| GSK | 5 | $88 |
| Kaleo, Inc. | 4 | $75 |
| Inspire Medical Systems, Inc. | 3 | $61 |
| Stryker | 2 | $44 |
| Acclarent, Inc | 3 | $44 |
| Aytu Biopharma, Inc. | 1 | $36 |
| Tactile Systems Technology Inc | 2 | $32 |
| Intersect ENT, Inc. | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Medtronic | 1 | $19 |
| Eagle Pharmaceuticals, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| Aerin Medical Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| USWM, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$225
How this compares
$2,065 in reported general payments places this provider in the 70th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 19 | $71,884 |
| Dupixent PenDupilumab | 11 | $49,917 |
| XolairOmalizumab | 12 | $33,536 |
| Azelastine Hcl | 188 | $8,280 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,321 |
| Ipratropium Bromide | 182 | $5,707 |
| QnaslBeclomethasone Dipropionate | 13 | $3,983 |
| SynthroidLevothyroxine Sodium | 45 | $2,747 |
| Epinephrine | 11 | $2,405 |
| Famotidine | 278 | $2,403 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,317 |
| Pilocarpine Hcl | 28 | $1,632 |
| Pantoprazole Sodium | 121 | $1,454 |
| Sucralfate | 13 | $1,315 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $88 | $7,32111 claims |
| AbbVieSynthroid | $115 | $2,74745 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 362 otolaryngology providers in North Carolina.
Other otolaryngology in Boone
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Adam CampbellWinston Salem$47K
- Harold PillsburyChapel Hill$42K
- John BuentingSylva$30K
- Brendan O ConnellCharlotte$28K
- Nicholas ThompsonChapel Hill$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.